These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7114977)
21. [Should we modify antipoliomyelitis vaccination?]. Frontera Izquierdo P An Esp Pediatr; 1986 Apr; 24(4):209-11. PubMed ID: 3729187 [No Abstract] [Full Text] [Related]
22. Ethical and safety considerations for the use in clinical trials of new attenuated poliovirus strains. Horaud F Dev Biol Stand; 1993; 78():149-54; discussion 154-5. PubMed ID: 8388825 [No Abstract] [Full Text] [Related]
25. Paralytic poliomyelitis--United States, 1980-1994. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844 [TBL] [Abstract][Full Text] [Related]
26. Poliovaccine policy--time for a change. Katz SL Pediatrics; 1996 Jul; 98(1):116-7. PubMed ID: 8668381 [No Abstract] [Full Text] [Related]
27. Coxsackie A7 virus and poliomyelitis in vaccines. Grist NR Lancet; 1969 Mar; 1(7594):575. PubMed ID: 4179865 [No Abstract] [Full Text] [Related]
28. Poliovaccination in the Gambia. Geffen T Lancet; 1987 Aug; 2(8557):511-2. PubMed ID: 2887803 [No Abstract] [Full Text] [Related]
29. Differential susceptibility of transgenic PVR Tg-mice to poliovirus strains with varying neurovirulence in relation with monkeys. Arya SC Biologicals; 1995 Jun; 23(2):191. PubMed ID: 7546663 [No Abstract] [Full Text] [Related]
30. Changing the US polio immunization schedule would be bad public health policy. Judelsohn R Pediatrics; 1996 Jul; 98(1):115-6. PubMed ID: 8668380 [No Abstract] [Full Text] [Related]
31. Reflections on the qualitative and quantitative aspects of neurovirulence of different polioviruses. Sabin AB Dev Biol Stand; 1993; 78():3-7. PubMed ID: 8388830 [No Abstract] [Full Text] [Related]
32. [Poliomyelitis: state of the art]. Patti AM Ann Ig; 2002; 14(4 Suppl 4):1-16. PubMed ID: 12389420 [No Abstract] [Full Text] [Related]
33. Poliomyelitis surveillance in Shandong Province, China, 1990-92. Chiba Y; Xu A; Li L; Lei T; Takezaki T; Hagiwara A; Yoneyama T; Fujiwara T; Hara M; Yamamoto T Bull World Health Organ; 1994; 72(6):915-20. PubMed ID: 7867137 [TBL] [Abstract][Full Text] [Related]
34. Paralytic poliomyelitis in Benin City in Nigeria. Offor E; Obi JO Public Health; 1986 Sep; 100(5):297-301. PubMed ID: 3786652 [No Abstract] [Full Text] [Related]
35. Changing poliovirus vaccine policy can be controversial at best. Faden H Adv Pediatr Infect Dis; 1997; 13():305-32. PubMed ID: 9544317 [No Abstract] [Full Text] [Related]
36. [Problems of diagnosis of poliomyelitis in a vaccinated population]. Voicoulesco M Rev Med Liege; 1965 May; 20(10):281-7. PubMed ID: 5834112 [No Abstract] [Full Text] [Related]
37. Polio vaccine: should New Zealand make the change? Baker C; Eberhart-Phillips J N Z Med J; 1997 Sep; 110(1051):340-2. PubMed ID: 9323376 [No Abstract] [Full Text] [Related]
39. Changing to injectable polio vaccine. Durham G N Z Med J; 1997 Oct; 110(1054):402. PubMed ID: 9397086 [No Abstract] [Full Text] [Related]
40. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative. Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]